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Abstract
Background: The temporal order of allelic replication is interrelated to the epigenomic profile. A
significant epigenetic marker is the asynchronous replication of monoallelically-expressed genes
versus the synchronous replication of biallelically-expressed genes. The present study sought to
determine whether a microdeletion in the genome affects epigenetic profiles of genes unrelated to
the missing segment. In order to test this hypothesis, we checked the replication patterns of two
genes – SNRPN, a normally monoallelically expressed gene (assigned to 15q11.13), and the RB1, an
archetypic biallelically expressed gene (assigned to 13.q14) in the genomes of patients carrying the
22q11.2 deletion (DiGeorge/Velocardiofacial syndrome) and those carrying the 7q11.23 deletion
(Williams syndrome).
Results: The allelic replication timing was determined by fluorescence in situ hybridization (FISH)
technology performed on peripheral blood cells. As expected, in the cells of normal subjects the
frequency of cells showing asynchronous replication for SNRPN was significantly (P < 10-12) higher
than the corresponding value for RB1. In contrast, cells of the deletion-carrying patients exhibited
a reversal in this replication pattern: there was a significantly lower frequency of cells engaging in
asynchronous replication for SNRPN  than for RB1  (P < 10-4  and P < 10-3  for DiGeorge/
Velocardiofacial and Williams syndromes, respectively). Accordingly, the significantly lower
frequency of cells showing asynchronous replication for SNRPN than for RB1 is a new epigenetic
marker distinguishing these deletion syndrome genotypes from normal ones.
Conclusion: In cell samples of each deletion-carrying individual, an aberrant, reversed pattern of
replication is delineated, namely, where a monoallelic gene replicates more synchronously than a
biallelic gene. This inverted pattern, which appears to be non-deletion-specific, clearly distinguishes
cells of deletion-carriers from normal ones. As such, it offers a potential epigenetic marker for
suspecting a hidden microdeletion that is too small to be detected by conventional karyotyping
methods.
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Background
Microdeletion syndromes are defined as viable human
(constitutional) chromosomal aberrations, each resulting
from a small hemizigous loss of DNA (ranging ~1–5 Mb).
These losses cannot be detected by conventional karyotyp-
ing methods, whose best resolution is no greater than 5
Mb [1,2]. The various microdeletion syndromes are esti-
mated to be among the major causes of mental retarda-
tion following Down and Fragile × syndromes [3]. Each is
associated with multiple abnormalities in various organ
systems, none of which, except for the missing DNA mate-
rial, is specific or unique to the microdeletion in question,
as all occur in the general population as well. However,
what makes each syndrome specific and unique is the sum
total of the abnormalities observed in each condition,
although in the total population of patients each syn-
drome abnormality is highly variable in its presentation.
This is exemplified by the wide spectrum of phenotypic
variations characterizing DiGeorge/Velocardiofacial syn-
drome (DGS/VCFS), and by the variability in expression
of Williams syndrome, each of which results from a sub-
microscopic loss of a tiny chromosomal segment. The
large spectrum of anomalies in DGS/VCFS is associated
with a deletion in chromosome band 22q11.2, while the
variable clinical expression in Williams syndrome results
from a deletion in 7q11.23 [4-7]. This permits to put for-
ward the hypothesis that, in addition to the direct impact
of the missing DNA, the "tiny monosomic status" by itself
may also be implicated in the prenatal malformations and
postnatal defects that define the affected phenotype. In
view of that, a quantitative imbalance per se resulting from
the missing DNA may disrupt the normal behavior of
other DNA sequences that are present in the aberrant
genome in their normal two doses. If, indeed, the loss of
one copy of a tiny chromosomal segment can cause a
broad spectrum of genomic malfunctions, one should
expect to find various non-deletion-specific alterations in
the epigenetic properties of various genes (including those
situated on chromosomes other than that on which the
deletion is situated). To test this hypothesis we examined
the temporal order of allelic replication, a marker reflect-
ing epigenetic qualities [reviewed in [8]; see also the next
paragraph], of two unrelated genes, SNRPN on chromo-
some 15q11-13 and RB1 on chromosome 13q14, in two
microdeletion syndromes, DGS/VCFS and Williams syn-
drome. These two syndromes were chosen because they
differ in the missing DNA information, as well as the chro-
mosome on which the missing DNA is located.
A dominant aspect of the inherent epigenomic profile is
the exact timing of DNA synthesis at the S-phase of the cell
cycle [9-11]. Usually, active loci replicate earlier than
silent ones [9,12]. An archetypal example of the close cor-
relation between replication timing and epigenetic inac-
tivity is the difference in replication timing between the
active and inactive X-chromosomes in mammalian
female cells, whereby the inactive chromosome replicates
considerably later than its active counterpart [13,14]. Fur-
thermore, the close connection between replication tim-
ing and epigenetic silencing is apparent from the fact that
the allelic counterparts of monoallelically expressed genes
replicate asynchronously, while the allelic counterparts of
biallelically expressed genes replicate synchronously
[8,15,16]. A simple method for evaluating the temporal
order of allelic replication is the fluorescent in situ hybridi-
zation (FISH) assay [17,18]. With this assay, it has been
demonstrated that allelic counterparts of monoallelically
expressed genes show asynchronous replication, with the
active allele replicating earlier than the inactive counter-
part [18-22]. The asynchronous pattern of allelic replica-
tion has been demonstrated in all known types of
monoallelically expressed genes. These include: (i)
imprinted genes, well exemplified by the SNRPN  gene
located within the Prader-Willi/Angelman syndrome
imprinted region, which shows early replication of the
active (paternal) allele and late replication of the inactive
(maternal) allele [18-22]; (ii) genes subjected to X-chro-
mosome inactivation [23-25]; and (iii) genes undergoing
allelic exclusion [8,26-34]. Therefore, the timing of repli-
cation of two allelic counterparts (either synchronous or
asynchronous), not necessarily in the tissue of expression,
is considered to be a marker for the epigenetic properties
of the gene in question [30,32-34].
In this study, we have shown in genomes containing a
microdeletion, that certain genes, even those unrelated to
the deletion, change their characteristic replication prop-
erties. Specifically, an imprinted gene (SNRPN) reveals
relaxation of the asynchronous pattern of replication,
characterizing monoallelic expression, whereas genes
(RB1 and ARSA) that normally show synchronous pat-
terns of replication alter their inherent mode and replicate
asynchronously. We also found that when a gene repli-
cates asynchronously due to the presence of a deletion,
the preference of an allele for early or delayed replication
is random.
Methods
Subjects and cell cultures
Peripheral blood samples obtained from 58 individuals
belonging to three different groups of subjects who were
referred for cytogenetic testing were used in this study. The
first group comprised 30 healthy individuals taken among
couples referring to the cytogenetic laboratory due to
recurrent pregnancy loss, all of whom were found to have
a normal karyotype (designated C1–C30); the second
group consisted of 18 patients diagnosed with DGS/VCFS
(designated V1–V18), all of whom carried the definitive
22q11.2 deletion confirmed by FISH analysis (Figure 1);
and the third group included ten patients with WilliamsMolecular Cytogenetics 2009, 2:11 http://www.molecularcytogenetics.org/content/2/1/11
Page 3 of 12
(page number not for citation purposes)
syndrome (cases W1–W10), each of whom carried the
characteristic 7q11.23 deletion confirmed by FISH. All the
samples were incubated for 72 hours in RPMI 1640
medium supplemented with 20% fetal calf serum (FCS),
3% phytohemagglutinin (PHA) and 1% antibiotics (a
standard solution of penicillin, streptomycin and nysta-
tin) at 37°C. Eight control samples (C1–C8), one sample
from the DGS/VCFS group (V1) and one sample from the
Williams syndrome group (W1) were divided into two
cultures, and one culture of each was pulsed-labeled at the
S-phase by adding 5'-bromo-2'-deoxyuridine (BrdU; MP
Biomedicals, Irvine, CA). At the end of the incubation
period, BrdU was added to these cultures at a final concen-
tration of 10-5 M for 90 min at 37°C, followed by a wash
with phosphate buffered saline (PBS). Colcemid (Biolog-
ical Industries, K. Beit-Haemek, Israel) was then added to
all the samples, both labeled and unlabeled with BrdU, at
a final concentration of 0.1μg/ml for 20 min, followed by
hypotonic treatment (0.075-M KCL at 37°C for 15 min)
and five washes, each with a fresh cold 3:1 methanol:ace-
tic acid solution.
Probes
Three directly labeled chromosomal probes from Vysis
(Doweners Grove, IL, USA) were used: (i) the RB1 probe
(32-192018) located on chromosome 13q14; (ii) the
SNRPN  probe (32-190004) located on chromosome
15q11-13; and (iii) the green-labeled ARSA probe (32-
191028) located on chromosome 22q13.3, which is com-
mercially mixed with the red-labeled TUPLE1  probe
located on chromosome 22q11.2. In cases with an
absence of one copy of 22q11.2, this two-probe combina-
tion enabled us, even at interphase, to determine whether
an ARSA signal was located on the homologue containing
the deletion or on the normal partner (Figure 1).
In-situ hybridization
Each probe was mixed with a hybridization solution and
poured onto the fresh slide spreads, covered with a 12 mm
cover slip and sealed with rubber cement. Co-denatura-
tion was performed at 76°C for six min followed by 18 hrs
hybridization at 37°C in a moist chamber. Following
hybridization the slides were washed in 0.4 × SSC/0.3%
NP40 at 53°C for 2 min and in 2 × SSC/0.1% NP40 at
room temperature for 1 min. After the second washing the
slides with the BrdU-labeled samples were incubated with
a blocking solution consisting of 1% Bovine serum albu-
min (BSA, Boerhinger-Mannheim) in 4 × SSC at 37°C for
30 min. At the same time the non-labeled slides were
counterstained with DAPI (4,6-diamidino-2-phenylin-
dole, Vector Laboratories Inc., Burlingame, CA) antifade
solution and analyzed for simultaneous viewing of FITC,
Texas red and DAPI.
Detection of BrdU-labeled samples
After blocking, BrdU was detected by anti mouse antibody
conjugated to AMCA (Jackson Immunoresearch Laborato-
ries, West Grove, PA, USA) linked by mouse anti-BrdU
antibody (Dako Cytomation, Glostrup, Denmark). The
two antibodies were diluted to the appropriate concentra-
tions in a solution of 4 × SSC with 1% BSA. The slides
were incubated with each antibody for 30 min at 37°C,
and each incubation was followed by 3 washes in PBS/
0.1% Triton × 100 at room temperature for 5 min. After
the final washing, the slides were mounted with an anti-
fade solution (Vectashield, Vector Laboratories, Burlin-
game, CA
Cytogenetic evaluation
The slides were analyzed blindly on an Olympus BX51
fluorescent microscope fitted with a triple band-pass filter
(Chroma Technology, Brattleboro, VT, USA) for the
simultaneous detection of three colors: blue-DAPI and
AMCA, green-FITC and red-rhodamine or Texas Red.
We used the FISH replication assay to determine whether
the replication patterns of three loci, RB1, SNRPN and
ARSA, in samples of control individuals and patients with
microdeletion syndromes were synchronous or asynchro-
nous. For each case, each probe and each BrdU-labeled
and unlabeled sample we analyzed at least 100 interphase
cells that showed, following FISH, two clearly stained
hybridization signals (Figure 2). We noted the structure of
each fluorescent signal in these cells – i.e. whether it was
Cells from a patient with DGS/VCFS, following two-color  FISH with TUPLE1 (red) and ARSA (green) Figure 1
Cells from a patient with DGS/VCFS, following two-
color FISH with TUPLE1 (red) and ARSA (green). 
Right, a metaphase-spread with the normal chromosome 22, 
identified by double labeling (red and green signals) and the 
deletion-carrying one, distinguished by the absence of the red 
signal; left, an interphase cell exemplifying two ARSA (green) 
signals and a single TUPLE1 (red) signal. The green signal that 
is closer to the red was assumed to belong to the normal 
homologue, while the more distant one to the deletion-car-
rying homologue.Molecular Cytogenetics 2009, 2:11 http://www.molecularcytogenetics.org/content/2/1/11
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a singlet (S), representing a non-replicated sequence, or a
doublet (D), indicating a replicated sequence. Accord-
ingly, the cells were classified into three categories: (i)
cells with two singlets (SS cells; Figure 2a, b, c); cells with
two doublets (DD cells; Figure 2d, e, f); and (iii) cells with
one singlet and one doublet (SD cells; Figure 2g, h, i).
Thus, in a population of replicating cells, following
hybridization with a locus specific probe, the frequency
(%) of cells containing two signals differing in their repli-
cation status (SD cells), out of the total population of cells
with two hybridization signals, represents the level of
asynchrony in the replication timing of the allelic counter-
parts of the locus in question.
In order to differentiate in the interphase cell samples of
the DGS/VCFS patients between the ARSA locus located
on the deletion-carrying homologue and the one situated
on the normal chromosome, we used the signal of the
TUPLE1 allele as a reference point. We assumed that the
ARSA allele that is closer to the TUPLE1 allele is located on
the normal chromosome whereas its counterpart is
located on the chromosome carrying the deletion (Figure
1).
Statistical method
The statistical significance of the differences between the
two cell populations tested was determined by the two-
tailed Student's t-test.
Ethical basis
The study was approved by the Rabin Medical Center
Review Board
Results
The frequency of SD cells for the RB1 locus in PHA-stim-
ulated lymphocytes of control subjects (cases C1–C15)
ranged from 16% to 30% with a mean and standard devi-
ation value of 20.3 ± 3.7% (Figure 3a). Specifically, in 14
out of the 15 control subjects tested the RB1 locus showed
a low frequency of SD cells (less than 25%) (Figure 3a). In
contrast, as expected for an imprinted locus, in a group of
10 control subjects (cases C16–C25) the frequency of SD
cells for the SNRPN locus was almost twice as high as that
found for the RB1 locus, ranging from 44% to 57% with a
mean and standard deviation value of 50.3 ± 4.2% (Figure
3b). Clearly, in cells of control subjects the imprinted
SNRPN locus shows significantly higher frequencies of SD
cells compared to RB1 (P < 10-12).
However, in the cell samples from the DGS/VCFS and the
Williams syndrome patients, the frequency of SD cells for
the imprinted SNRPN locus were significantly lower than
the corresponding values for RB1 (P < 0.001 for the DGS/
VCFS patients and P < 0.0002 for those with Williams syn-
drome; Figure 3c, d, e, f). Specifically, the frequency of SD
cells for SNRPN  in the samples from the DGS/VCFS
patients ranged from 23% to 33% with a mean of 27.8 ±
3.1%, and the corresponding RB1  values ranged from
29% to 45% with a mean of 35.7 ± 5.0% (Figure 3c and
Figure 3d). Similarly, the frequency of SD cells in the sam-
ples from the Williams syndrome patients ranged from
12% to 31% for the SNRPN locus and from 29% to 51%
for the RB1 locus with a mean of 23.4 ± 6.5% and 36.2 ±
6.7%, respectively (Figure 3e and Figure 3f).
The considerably low frequency of SD cells for SNRPN
found in the samples of the two groups of patients with
the deletion syndromes were similar to each other (P >
0.05), but each deviated significantly from those charac-
terizing the samples of the control group (P < 10-9 and P <
10-7, for DGS/VCFS and Williams syndromes, respec-
tively) (Table 1; Figure 3b, d and Figure 3f; Figure 4a). The
samples of the two groups with the deletion syndromes
also showed similar SD frequencies for RB1 (P > 0.80),
which were significantly higher than the corresponding
RB1 value observed in the control group of samples (P <
10-6 and P < 10-4, for DGS/VCFS and Williams syndromes,
respectively) (Table 1; Figure 3a, c and Figure 3e; Figure
4a).
When the SD frequencies for RB1 were analyzed in distin-
guishable (BrdU-labeled) S-phase cell populations from
eight control subjects (cases C1–C8) and two patients
(cases V1 and W1), it was seen that each of the two cases
with the deletion syndrome revealed in the BrdU-labeled
S-phase cell population a high frequency of SD cells for
RB1 (42% and 46%, for V1 and W1, respectively), similar
to the corresponding value obtained in the unlabeled S-
phase cell population (Figure 5). Also, each of the control
samples tested showed, for RB1, a frequency of SD cells in
the S-phase labeled cell population similar to the corre-
sponding value obtained in the unlabeled cell population
(less than 24%) (Figure 5).
As judged from the frequencies of the SS- and DD- cells for
RB1 in the three groups of samples tested, it appears that
the increased frequency of SD cells for RB1 in the patients
with a deletion syndrome results from delay in replication
of a single RB1 allele. Specifically, in each group with a
deletion syndrome, the frequency of SS cells for RB1 was
similar to the corresponding value in the control group.
However, the frequency of DD cells in each group with a
deletion syndrome was significantly lower than the corre-
sponding value in the control group (Table 1; Figure 4b
and Figure 4c).
When analyzing the frequencies of the SS and DD cells for
SNRPN, it appears that the decreased frequency of SD cells
observed in the DGS/VCFS patients is accompanied by a
statistically significant increase in the frequency of DDMolecular Cytogenetics 2009, 2:11 http://www.molecularcytogenetics.org/content/2/1/11
Page 5 of 12
(page number not for citation purposes)
cells but not of SS cells, while the decreased frequency of
SD cells observed in the Williams syndrome patients is
associated with an increase in the frequency of SS cells but
not of DD cells (Table 1; Figure 4b and Figure 4c).
Finally, in order to determine whether proximity to a
deleted region affects the replication timing properties of
an adjacent locus we studied the replication mode of the
ARSA alleles in cell samples from ten DGS/VCFS patients
(cases V1–V4, V11–V13 and V16–V18) and five control
subjects (cases C26–C30) (Figure 1). We found that the
frequency of SD cells for the ARSA locus in the samples
from the patients was significantly higher than that
observed in the control samples (P < 10-5) (Figure 6a and
Figure 6b). It appears that the ARSA locus mimics the
behavior of the RB1 locus, exhibiting SD frequencies in
control samples that were significantly lower than the cor-
responding SNRPN values (P < 10-9), and levels in sam-
ples from subjects carrying a microdeletion that were
significantly higher than the corresponding SNRPN values
(P < 0.0003). However, the replication timing behavior of
the ARSA allele located on the homologue carrying the
deletion was similar to that of its counterpart situated on
the normal chromosome. Therefore, it appears that the
ARSA allele on the homologue with the deletion, as com-
pared to its counterpart, showed neither a greater ten-
dency for earlier replication (D signal) nor an increased
preference for delayed replication (S signal). This shows
that in each SD cell population of the ten DGS/VCFS cases
studied, the preference for early or late replication of the
ARSA allele located on the deletion-carrying homologue
was random (P > 0.50; Figure 6c).
Discussion
Our results are in accordance with data showing that the
SNRPN-imprinted locus – the hallmark of monoallelic
expressed genes – normally exhibits asynchronous repli-
cation [8,30,32]. It has also been well documented that
the expressed allele, which in the case of the SNRPN gene
is the paternal allele, replicates earlier than its counterpart
[16,20]. Clearly, the SNRPN pattern of replication differs
markedly from the common synchronous pattern charac-
terizing most genes in the human genome – namely, the
biallelically expressed genes [12], exemplified here by RB1
and ARSA.
However, in the cells of microdeletion syndrome patients
(of 22q11.2 or 7q11.23), the SNRPN gene revealed a loss
of its asynchronous pattern of replication. In addition, in
cells of the patients, the RB1 and the ARSA loci also exhib-
ited replication-timing alterations, that is, both these
genes demonstrated an asynchronous replication pattern.
Consequently, an abnormal epigenetic profile is deline-
ated inside genomes carrying a deleterious microdeletion,
in which allelic counterparts of an imprinted locus repli-
cate more synchronously than allelic counterparts of bial-
lelically expressed loci.
It is clear that the considerably low frequency of SD cells
for SNRPN in the deletion syndrome cases we studied can-
not be attributed to a shortening of the duration of the S-
phase, since there was a concomitant, significant increase
in the frequency of SD cells for RB1. On the other hand,
while an increase in the S-phase duration may explain the
increase in the frequency of SD cells for RB1, it fails to
explain the dramatic decrease in the frequency of SD
observed for SNRPN. Furthermore, the S-phase-labeled
cell population revealed similar values for RB1 to those
obtained in the unlabeled cell population. Thereby, indi-
cating directly that the duration of the S-phase was not
associated with an alteration in the replication timing
accompanying the deletion syndromes.
Since the loci studied here were selected at random, unre-
lated to the deletions in question, we hypothesize that
other monoallelically expressed loci (in addition to
SNRPN), as well as other biallelically expressed ones (in
addition to RB1 and ARSA), in these genomes may also
exhibit replication timing alterations. Considering the
strong correlation between replication timing and epige-
netic characteristics, it is reasonable to assume that the
Fluorescent signals in PHA-stimulated lymphocytes at inter- phase, following FISH with RB1 Figure 2
Fluorescent signals in PHA-stimulated lymphocytes 
at interphase, following FISH with RB1. (a) – (c) cells 
with two singlets (SS cells) in which neither allele has repli-
cated; (d) – (f) cells with two doublets (DD cells) in which 
both alleles have replicated; and (g) – (i) cells with one singlet 
and one doublet (SD cells), which are S-phase cells in which 
one allele has replicated while its partner has not.Molecular Cytogenetics 2009, 2:11 http://www.molecularcytogenetics.org/content/2/1/11
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The frequency of SD cells for RB1 and SNRPN Figure 3
The frequency of SD cells for RB1 and SNRPN. (a) and (b), samples from control individuals; (c) and (d), samples from 
patients with DGS/VCFS; and (e) and (f), samples from patients with Williams syndrome. The P values in frames (a), (c) and (e) 
represent the level of significance of the differences in the frequency of SD cells between RB1 and SNRPN within a given group 
of samples. The mean frequency and standard deviation for each locus in each group of samples are also shown (last bar in each 
frame).Molecular Cytogenetics 2009, 2:11 http://www.molecularcytogenetics.org/content/2/1/11
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global replication timing modifications displayed within
the deletion-carrying genomes lead to major alterations in
the epigenomic features. This reasoning is in line with the
view that the replication timing is both the cause and the
consequence of the chromatin structure of a gene [9]. We
have shown here that alleles of a gene that is normally
subject to monoallelic expression fail to keep the inherent
functional asymmetry between the allelic counterparts
necessary for establishing normal phenotypes. Con-
versely, the normally biallelically expressed loci fail to
keep the functional symmetry between parental counter-
parts required to fulfill Mendelian laws. This loss of sym-
metry in deletion-carrying genomes for alleles of
biallelically expressed genes co-occurring with loss of the
inherent capability of exclusively specialized genes for
allele-specific behaviour, may explain the numerous and
variable, non-deletion-specific abnormal traits that
accompany both of these microdeletion syndromes.
Interestingly, in the DGS/VCFS group the loss of replica-
tion asynchrony observed for the SNRPN locus is mainly
due to an advanced replication of the normally late-repli-
cating (maternal) allele, while the loss of asynchrony for
SNRPN in the Williams syndrome patients is mostly asso-
ciated with a delay in the replication timing of the nor-
mally early-replicating (paternal) SNRPN allele. Yet, it is
illogical to assume that the deletion in question "recog-
nizes" whether a far-removed allele is maternal or pater-
nal in origin through some parent-of-origin inborn signal.
The differentiation is possibly based on the epigenetic dif-
Table 1: Level of significance (P) of the differences in corresponding SD, SS and DD values between the designated groups
SD SS DD
RB1 SNRPN RB1 SNRPN RB1 SNRPN
Control vs. DGS/VCFS P < 10-6 P < 10-9 P > 0.50 P > 0.10 P < 0.05 P < 0.05
Control vs. Williams P < 10-4 P < 10-7 P > 0.05 P < 0.0005 P < 10-4 P > 0.40
DGS/VCFS vs. Williams P > 0.80 P > 0.05 P > 0.40 P < 0.01 P > 0.05 P < 0.05
Control group (cases C1–C15 for RB1 and C16–C25 for SNRPN); DGS/VCFS group (cases V1–V10 for RB1, and cases V1, V5–V7, V9, V11–V15 for 
SNRPN); and Williams syndrome group (cases W1–W10).
Mean frequency values for SD, SS and DD cells for RB1 and SNRPN in control and patient samples Figure 4
Mean frequency values for SD, SS and DD cells for RB1 and SNRPN in control and patient samples. Solid bars 
present the control sample (cases C1–C15 for RB1 and C16–C25 for SNRPN); striped bars present the sample of patients with 
DGS/VCFS (cases V1–V10 for RB1, and V1, V5–V7, V9 and V11–V15 for SNRPN); and dotted bars present the sample of 
patients with Williams syndrome (cases W1–W10).Molecular Cytogenetics 2009, 2:11 http://www.molecularcytogenetics.org/content/2/1/11
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ferences characterizing alleles of the imprinted locus that
were established in the parental germ cells prior to fertili-
zation [35]. Whatever the reason for the differences in
SNRPN  replication behavior in the two deletion syn-
dromes, it clarifies how loss of asynchronous replication,
even for a single and specific monoallelic gene, may lead
(in addition to non-deletion-specific malformations) to
syndrome-specific abnormal phenotypic expression. It is
interesting to note that relaxation of imprinting, arising
either from activation of the silent allele or from silencing
of the normally active allele was documented previously
in association with the numerous, variable epigenetic
alterations characterizing malignant phenotypes [36].
One could speculate, therefore, that each microdeletion
shows specificity toward a particular epigenetic profile,
and if the two parental allelic counterparts retain the same
structure, they are not differentiated specifically by the
deletion in question. This view is in accordance with the
replication pattern of the ARSA locus, which replicates
synchronously in normal cells, and as such its alleles are
expected to have initially (at fertilization) similar epige-
netic structures. Indeed, our results show that in cells car-
rying the 22q11.2 deletion, the asynchronous replication
of the ARSA locus resulted from a random preference of
an allele for early or late replication, probably determined
de-novo for each replication cycle. This is inferred from the
observation that in half (about 50%) of each population
of SD cells from patients with the 22q11.2 deletion, the
allele located on the homologue carrying the deletion was
the early-replicating allele, while in the other half its coun-
terpart was the early one. Additionally, it indicates that an
allele located distally to the deleted region, on the same
chromosomal arm, behaves similarly to its counterpart
located on the normal arm. Together, our results disagree
with the notion that asynchronous replication in a dele-
tion-carrying genome results merely from a type of posi-
tion-effect (change in position along the chromosome) of
the allele located on the deletion-carrying homologue
[37]. Our results are in agreement with a short report
claiming that the presence of a microdeletion within the
genome increases the level of replication asynchrony of
biallelically expressed genes not located on the deletion-
carrying chromosome [38]. Furthermore, we show here
that the asynchronous pattern of replication of bialleli-
cally expressed loci, exemplified by RB1 in cells with a
22q11.2 deletion, as well as those with a 7q11.23 dele-
tion, appears to result from a delay in replication of a sin-
gle allele (inferred by a decrease in the frequency of DD
cells but not of SS cells). Yet, based on the replication pat-
tern of the ARSA  locus, which mimics the replication
behavior of the RB1 locus, it is reasonable to assume that
in a deletion-carrying genome, the preference of a specific
allele of a biallelically expressed gene for delayed replica-
tion is also random. It is therefore independent of any
kind of position effect. This is supported by a study in cells
with a 22q11.2 deletion that the TUPLE1 allele, situated
on the intact chromosome 22 within the 22q11.2 region,
presents a delayed replication timing [6].
Asynchronous replication of biallelically expressed loci
has been reported in cells from patients carrying an aneu-
ploidic loss of the whole X-chromosome (Turner syn-
drome, shown in peripheral blood cells) [39] or the gain
of an autosome (trisomies 21, 18 and 13, shown in amni-
otic fluid cells) [40,41]. In these whole-chromosome ane-
uploidies [39-41], the biallelically expressed loci that were
shown to change their characteristic synchronous pattern
of replication to an asynchronous one were not associated
with the lost or gained chromosome. Taken together, it is
reasonable to assume that the phenomenon of replica-
tion-timing alteration in loci unrelated to the imbalance-
causing-DNA sequence is not specific to the size or type of
the lost/gained chromosomal segment (or whole chromo-
some). Thus, the view that a specific gene(s) assigned to
the missing segment, in each of the microdeletion geno-
types studied here, is the sole cause of the global replica-
tion timing aberrations is weakened. This reasoning
remains coherent even in light of the information that the
deletion of the DGS/VCFS is gene-dense [reviewed in [6]]
and the deletion of the Williams syndrome carries a gene
(RFC2) that codes for a subunit of a replication factor, a
part of the multimeric complex involved in DNA elonga-
tion during replication [7]. Furthermore, even the view
that replication-timing alterations are associated with an
existing predisposition factor that destabilizes the integ-
rity of the genome appears to be incompatible with the
Frequency of SD cells for RB1 in BrdU-labeled and unlabeled  cell populations Figure 5
Frequency of SD cells for RB1 in BrdU-labeled and 
unlabeled cell populations. Control individuals (cases 
C1–C8), a patient with DGS/VCFS (case V1) and a patient 
with Williams syndrome (case W1). Each sample is shown 
with two SD values for RB1, one in an unlabeled cell popula-
tion (open bars) and the second in a BrdU labeled population 
(solid bars).Molecular Cytogenetics 2009, 2:11 http://www.molecularcytogenetics.org/content/2/1/11
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Frequency of SD cells for ARSA in samples from control individuals and from patients with DGS/VCFS Figure 6
Frequency of SD cells for ARSA in samples from control individuals and from patients with DGS/VCFS. In frame 
(c) the frequency of SD cells in each individual sample was separated into two sub-categories: cells in which the ARSA signal of 
the deletion-carrying homologue shows a singlet (S-signal, open bar) and those in which the ARSA signal of the deletion-carrying 
chromosome reveals a doublet (D-signal, solid bar). The mean frequencies and standard deviations for each group of samples 
are also given (last bar(s) in each frame). The P value in frame (a) represents the significance of the difference between the val-
ues in frames (a) and (b); the P value in frame (c) shows the significance of the difference between the S and D values for the 
ARSA signal of the deletion-carrying homologue within the total ARSA SD cell population.Molecular Cytogenetics 2009, 2:11 http://www.molecularcytogenetics.org/content/2/1/11
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current data; any potential destabilizing mechanism lead-
ing to a segmental deletion/duplication [4,5,42,43] is
entirely different from that giving rise to the loss/gain of a
whole chromosome [44]. Therefore, it is more logical to
assume that the global alteration in allelic replication tim-
ing results from the aneuploidic status itself. This is in
accordance with data showing that peripheral blood cells
derived from individuals with normal karyotypes, which
show increased levels of sporadic (non-chromosome spe-
cific) aneuploidy due to malignancy, exhibit replication
timing modification of various loci unrelated to the miss-
ing/gained chromosomes [45-47]. This further strength-
ens the notion that the nature of the missing/gained genes
assigned to the lost/gained DNA is not imperative to the
replication anomaly described here.
Yet, the non-locus-specific aberrant replication timing in
the cells of cancer patients was reverted to normal in the
presence of 5-azacytidine, a classical methylation-block-
ing agent, recently approved as an anti-cancer drug [48],
thereby linking replication timing alteration to methyla-
tion capacity [46,47,49]. This agrees with our previous
studies in cells of mutation carriers [25] and patients with
the fragile × syndrome [50], where we showed that the
mutated (FMR1) allele (characterized by highly methyl-
ated tri-nucleotide repeats) demonstrated delayed replica-
tion, which was restored by the application of a
demethylating drug [50]. Similarly, replication studies in
cells of girls with Rett syndrome link loss of asynchronous
replication of X-linked genes with DNA methylation [51].
Rett syndrome is caused by a mutation in an X-linked
gene (MECP2) that normally codes for a protein capable
of binding to methylated DNA; it therefore takes part in
the line of events leading to transcriptional silencing of X-
inactivated genes [reviewed in [52]].
The involvement of methylation capacity with replication
timing is not surprising since allelic counterparts, which
exhibit normally asynchronous replications are most
often differentially methylated [8,12]. It is therefore rea-
sonable to assume that also the aberrant replication
accompanying a microdeletion is associated with aberrant
methylation. It is yet not clear if independent mechanisms
control allelic replication timing (synchronous or asyn-
chronous) and methylation capacity (similar or differ-
ent). Nevertheless, the non-random spatial organization
of homologous DNA segments in the diploid nucleus was
suggested to play a critical role in both replication timing
and methylation capacity [8,12]. Furthermore, numerous
studies also show that DNA spatial organization in the
diploid nucleus is most crucial for epigenomic stability
and proper gene functioning [reviewed in [53]]. There-
fore, it is tempting to speculate that the loss/gain of a sin-
gle chromosomal segment (or whole chromosome)
disrupts the structural unity of the diploid status, altering
the overall spatial organization of chromosomes within
the interphase nucleus. This in turn leads to (non-gene
specific) epigenetic alterations of genes situated on chro-
mosomes other than those carrying the aberration, as well
as those located on the aberrant chromosome. This spec-
ulation is supported in part by data showing that in cells
of DGS/VCFS patients the intact chromosome 22 displays
a specific (peripheral) nuclear location, which is different
from that observed in normal cells, for two intact (fully
homologous) chromosomes 22 [6].
Whatever the mechanism underlining abnormal allelic
replication timing, the epigenetic alteration delineated by
the deletion is not deletion-specific, and probably accom-
panies any loss/gain of a whole chromosome or of a small
chromosomal segment. As such, abnormal allelic replica-
tion timing offers a potential epigenetic marker, a kind of
a preliminary hint to suspect the existence of any type of
chromosomal imbalance. For instance, the replication-
timing test can be used to investigate unexplained cases of
mental retardation as well as other phenotypic abnormal-
ities suspected to arise from minute segmental aneuploidy
that cannot be seen by conventional karyotyping [1,54].
Specifically, cases showing a higher level of asynchrony
for a biallelic gene compared to that observed (in the very
same cell sample) for a monoallelic one, call for further
investigations. Moreover, the global epigenetic alteration,
as described here in PHA-stimulated lymphocytes of
microdeletion-carrying patients, probably appears in pre-
natal tissues as well, as can be inferred from the high asyn-
chronous replication of biallelically expressed loci
observed previously in the amniotic fluid cells of cases
with trisomies 21, 18 and 13 [40,41]. It is therefore rea-
sonable to assume that observation of a reversal of the
replication patterns in amniotic cells might mark a fetus
that has inherited a chromosomal imbalanced genome
and thus, it calls for further attention. One could seek to
apply more laborious and costly DNA analyses for exam-
ining the integrity of the entire chromosomal comple-
ment. These might include high-resolution array-based
comparative genomic hybridization techniques [2,3,54],
capable of characterizing the specific DNA segment
incriminated in a chromosomal imbalance.
Finally, we would like to refer shortly to the abundance of
submicroscopic copy number variations (CNV) of DNA
segments ranging from a few kilobases (kb) to megabases
(Mb) in size recently discovered in the human genome,
whose impact upon the genome is still undefined [55,56].
It is worth examining whether those variations are accom-
panied by replication-timing alterations and whether
such alterations could be of use in differentiating between
deleterious and harmless CNVs.Molecular Cytogenetics 2009, 2:11 http://www.molecularcytogenetics.org/content/2/1/11
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Conclusion
Within genomes carrying a deleterious microdeletion, an
abnormal epigenetic profile is delineated in which allelic
counterparts of an imprinted gene, not directly associated
with the missing DNA, replicate more synchronously than
allelic counterparts of biallelically expressed loci. This epi-
genetic aberration, which appears to be non-deletion spe-
cific, is in line with the numerous non-deletion specific
phenotypic abnormalities usually accompanying each
microdeletion syndrome. Such an aberration, which is
easily detected by cytogenetic means, offers a potential
preliminary screening tool for such conditions, in effect,
an "epigenotype-first approach" that can be performed
without any prior information as to the specific genetic
nature of the underlying abnormality.
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